Filing Flows › Health Care › Global Innovative Platforms (GIPL)
Global Innovative Platforms (GIPL) earnings and revenue breakdown
Latest: Q3 FY26 · 10-Q filed Aug 14, 2026 · Global Innovative Platforms (GIPL) Q3 FY26 earnings results →
Q3 FY26 477¢ of every $1 of revenue lost · operating margin -476.6%
Global Innovative Platforms made $51K in Q3 FY26. Operating margin -476.6%, net loss $242K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $51K in Q3 FY26, down 52% from the previous quarter.
Operating costs exceeded revenue by $242K, an operating margin of -476.6%. The quarter ended with a net loss of $242K, wider than the previous quarter's $151K loss.
Operating cash flow was −$134K. Non-cash charges added back $12K of depreciation. Working capital and other items added $96K. Capital expenditures of $55K exceeded it, leaving free cash flow of −$189K.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 FY26 | 10-Q | Aug 14, 2026 | $51K | — | -476.6% | −$242K | −$134K |
| Q2 FY26 | 10-Q | May 20, 2026 | $106K | — | -142.1% | −$151K | −$149K |
| Q1 FY26 | 10-Q | Feb 17, 2026 | $30K | — | -164.8% | −$49K | $13K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Global Innovative Platforms
Global Innovative Platforms Inc. f/k/a Canning Street Corporation, a Delaware corporation, ( “Global Innovative Platforms”,” Canning Street,” the “Company”, “we,” “us” or “our”) is engaged in the business of testing breath to detect and assist in the treatment of disease. Global Innovative Platforms is focused on advancing animal health through breath analysis and air quality technology. We develop non-invasive diagnostic tools for detecting diseases, assessing treatment effectiveness. Our proprietary technologies, “VOCAM Plus” and the “FROG,” utilize advanced gas chromatography and A.I. software to provide rapid and accurate breath and air analysis. The Company’s mission is to revolutionize early detection of a wide array of animal related abnormalities. Applications range from disease and treatment effectiveness to potentially toxic environmental and food conditions.
In its own words, from its 10-K, filed Jan 13, 2026.
Global Innovative Platforms against its Surgical & Medical Instruments & Apparatus peers
The largest companies of the same SEC industry, each at its latest quarter. Operating margin: -476.6% against the peers' median 13.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| GIPL Global Innovative Platforms | Q3 FY26 | $51K | — | -476.6% |
| MDLN Medline | Q3 2026 | $7.9B | +10% | 6.4% |
| MMM 3M | Q3 2026 | $6.6B | +1% | 23.7% |
| SYK Stryker | Q3 2026 | $6.5B | +8% | 15.9% |
| BSX Boston Scientific | Q3 2026 | $5.1B | +1% | 16.1% |
| BDX Becton Dickinson | Q3 FY26 | $5.0B | +5% | 13.3% |
| BAX Baxter International | Q3 2026 | $3.0B | +5% | 7.6% |
| SOLV Solventum | Q3 2026 | $1.9B | -7% | 3.5% |
| RMD ResMed | Q1 FY27 | $1.4B | +6% | 32.0% |
Source: Global Innovative Platforms 10-Q on SEC EDGAR · CIK 1837774 · Surgical & Medical Instruments & Apparatus
More on GIPL
History
Every quarter: Q3 FY26 results · Q2 FY26 results · Q1 FY26 results